In an interview with Ophthalmology Times, Robert Latkany, MD, a New York ocular surface specialist, discusses lagophthalmos, the inability to fully close the eyelids, often leads to exposure keratitis, causing irritation and damage to the ocular surface. Common causes include individuals naturally sleeping with their eyes open, post-surgical changes from blepharoplasty or other … [Read more...] about Pearls for diagnosing lagophthalmos with exposure keratitis
News
What increased depth of focus can mean to your monofocal IOL patients
Historically, the goal with monofocal or monofocal toric IOLs has been to achieve the best possible distance vision—typically at the expense of intermediate and near vision.Our best monofocal IOLs have long utilized negative spherical aberration (SA) to neutralize the cornea’s positive SA and enhance quality of vision. Today’s advanced monofocal IOLs, however, employ a variety … [Read more...] about What increased depth of focus can mean to your monofocal IOL patients
Systemic adverse drug events to topical prostaglandin analogs for treating glaucoma: a retrospective focused pharmacovigilance study
Prostaglandin analogs are first-line treatments for open-angle glaucoma due to their proven efficacy in reducing intraocular pressure. Despite their topical administration, systemic adverse drug Events (ADEs) ... … [Read more...] about Systemic adverse drug events to topical prostaglandin analogs for treating glaucoma: a retrospective focused pharmacovigilance study
Cyclodialysis procedure with scleral reinforcement lowers IOP in open-angle glaucoma
December 30, 2024 1 min read Key takeaways: Cyclodialysis with scleral allograft reinforcement lowered IOP in patients with glaucoma. The treatment also displayed a positive safety profile. A bio-interventional cyclodialysis procedure with allograft scleral reinforcement helped lower IOP in patients with glaucoma through … [Read more...] about Cyclodialysis procedure with scleral reinforcement lowers IOP in open-angle glaucoma
Glaucoma: Top items in ophthalmology for 2024
December 30, 2024 1 min read The top glaucoma articles on Healio in 2024 included an overview of a more holistic approach to managing the disease as well as safety and efficacy data for a sustained-release bimatoprost drug delivery platform. Check out these stories and more below. Check out the top glaucoma articles on Healio in 2024. Image: Adobe Stock … [Read more...] about Glaucoma: Top items in ophthalmology for 2024
Wrapping up another year in eye care: 2024 in review from Ophthalmology Times Europe
Another year is coming to its end. We spent 2024 celebrating the 20th anniversary of Ophthalmology Times Europe. That milestone wouldn’t be possible without readers like you, who refer back to our print magazine, digital edition, eNewsletters and video interviews day after day. Throughout the year, our industry has experienced major victories. We’ve navigated challenges and … [Read more...] about Wrapping up another year in eye care: 2024 in review from Ophthalmology Times Europe
VIDEO: OCS-01 eye drop shows efficacy, safety for treatment of DME
December 30, 2024 3 min watch CHICAGO — In this Healio Video Perspective from the AAO meeting, Arshad M. Khanani, MD, MA, FASRS, shares promising data from an ongoing phase 2/3 study investigating OCS-01, an eye drop for the treatment of diabetic macular edema. “In stage one, we saw efficacy signals in every single parameter we looked at, … [Read more...] about VIDEO: OCS-01 eye drop shows efficacy, safety for treatment of DME
Playing matchmaker with Schlemm canal surgery
Reviewed by Sheng Lim, MD, FRCOphth; and Karl Mercieca, MD, FRCOphth, FEBOS-GLDuring the European Society of Cataract and Refractive Surgeons meeting, Sheng Lim, MD, FRCOphth, professor of glaucoma studies at St Thomas’ Hospital and King’s College London, both in England, and Karl Mercieca, MD, FRCOphth, FEBOS-GL, director of glaucoma services and lead surgeon at the University … [Read more...] about Playing matchmaker with Schlemm canal surgery
How intravitreal anti-vascular endothelial growth factor initial dosing impacts patient outcomes in diabetic macular oedema
Intravitreal anti-vascular endothelial growth factor (VEGF) treatment for diabetic macular oedema (DME) may begin with several initial monthly doses. Characteristics, treatment patterns and outcomes were compa... … [Read more...] about How intravitreal anti-vascular endothelial growth factor initial dosing impacts patient outcomes in diabetic macular oedema
Delayed spontaneous resolution of a double anterior chamber following deep anterior lamellar keratoplasty (DALK)
This study reports a rare case of delayed spontaneous resolution of double anterior chambers (AC) resulting from non-rhegmatogenous Descemet membrane detachment (DMD) after deep anterior lamellar keratoplasty ... … [Read more...] about Delayed spontaneous resolution of a double anterior chamber following deep anterior lamellar keratoplasty (DALK)